Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.
Evaluation of the Effect of Milk Based Infant Formula Supplemented Either With Probiotic Microorganisms and/or With Prebiotic on the Intestinal Microflora During the First 4 Months of Life of Healthy, Full Term Infants and it's Long Term Effect on Morbidity up to the Age of 9 Months
1 other identifier
interventional
270
1 country
1
Brief Summary
Evaluation the nutritional suitability of a based milk infant formula supplemented with friendly bacteria (probiotic microorganisms) and or nutritional fibers (prebiotic) to healthy, full term infants compare with an otherwise identical widely used commercially available milk based infant formula and/or breast feed
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2009
CompletedFirst Posted
Study publicly available on registry
February 4, 2009
CompletedStudy Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedJuly 31, 2013
May 1, 2012
4.5 years
February 3, 2009
July 30, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
weight gain
1 to 120 days of age
Secondary Outcomes (2)
Anthropometric
1-120 days of age
GI tolerance
1-120 days of age
Other Outcomes (1)
Influence on the microbial content of the stool
3 - 4 times: 1-16 d, 4 w 16 w and 36 w
Study Arms (5)
Materna infant formula 1
PLACEBO COMPARATORmilk based infant formula powder
Materna infant formula 2
EXPERIMENTALProbiotic supplemented infant formula
Materna infant formula 3
EXPERIMENTALPrebiotic supplemented infant formula
Materna infant formula 4
EXPERIMENTALPrebiotic+ Probiotic supplemented infant formula
Human milk
OTHERHuman Milk
Interventions
Eligibility Criteria
You may qualify if:
- Healthy term infants of both sexes, born in natural labor .
- Single birth.
- Full term infants (born between the 37th and 42nd week of gestation)
- Infants with birth weight \>2500 g.
- Recruitment age will be 0-21 days.
- Infants whose mothers are unable to breast feed or have chosen not to breast feed prior to the study enrollment.
- Infants whose parents have agreed to participate in the study up to the age of 9 months..
- Infants whose parents have agreed to remain exclusively on the same product for 16 weeks of age..
- Infants whose parents have signed the informed consent form.
- Infants whose parents are able to understand the protocol requirements and to fill out the infant's diary and agree to completely fill out the parents' questionnaires during the period Of 9 months
You may not qualify if:
- Twins.
- Premature or low birth weight (\< 2500 g).
- Chromosomal abnormalities or congenital malformation.
- Suffering jaundice which require phototherapy.
- Proven or suspected family history of allergy to cow's milk.
- Having been treated with antibiotics or other drugs during the last three days or more prior to the commencement of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neonatology department, Laniado Hospital- Sanz Medical Center, .
Netanya, Israel
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nehama Linder, M.D. Ph.D
Neonatology department, Rabin Medical center, Petach Tikva. Israel
- PRINCIPAL INVESTIGATOR
Raanan Shamir, M.D. Ph.D.
Institute of Gastroenterology Nutrition and Liver Diseases Schneider children medical center, Petach Tikva.
- PRINCIPAL INVESTIGATOR
Kobi Shiff, M.D.
Neonatology department, Laniado Hospital- Sanz Medical Center, Netanya, Israel.
- PRINCIPAL INVESTIGATOR
Zvi Weizman, M.D. Ph.D
Department of Pediatrics, Soroka University Medical Center, Beer-Sheva, Israel.
- PRINCIPAL INVESTIGATOR
Uri Rubenstein, M.D
clinic, 1 Yehuda Perach St., Natanya
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2009
First Posted
February 4, 2009
Study Start
July 1, 2009
Primary Completion
January 1, 2014
Study Completion
December 1, 2014
Last Updated
July 31, 2013
Record last verified: 2012-05